| Product Code: ETC9279211 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Neuroimaging Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Neuroimaging Market Revenues & Volume, 2021 & 2031F |
3.3 Singapore Neuroimaging Market - Industry Life Cycle |
3.4 Singapore Neuroimaging Market - Porter's Five Forces |
3.5 Singapore Neuroimaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Singapore Neuroimaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Singapore Neuroimaging Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Singapore Neuroimaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Singapore |
4.2.2 Growing adoption of advanced neuroimaging technologies |
4.2.3 Rise in healthcare expenditure and investments in medical infrastructure in Singapore |
4.3 Market Restraints |
4.3.1 High cost associated with neuroimaging procedures |
4.3.2 Limited availability of skilled professionals in the field of neuroimaging in Singapore |
5 Singapore Neuroimaging Market Trends |
6 Singapore Neuroimaging Market, By Types |
6.1 Singapore Neuroimaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Singapore Neuroimaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Singapore Neuroimaging Market Revenues & Volume, By Magnetic Resonance Imaging (MRI), 2021- 2031F |
6.1.4 Singapore Neuroimaging Market Revenues & Volume, By Computed Tomography (CT), 2021- 2031F |
6.1.5 Singapore Neuroimaging Market Revenues & Volume, By Positron Emission Tomography (PET), 2021- 2031F |
6.1.6 Singapore Neuroimaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT), 2021- 2031F |
6.1.7 Singapore Neuroimaging Market Revenues & Volume, By Functional Magnetic Resonance Imaging (fMRI), 2021- 2031F |
6.1.8 Singapore Neuroimaging Market Revenues & Volume, By Diffusion Tensor Imaging (DTI), 2021- 2031F |
6.1.9 Singapore Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Singapore Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Singapore Neuroimaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Singapore Neuroimaging Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.3 Singapore Neuroimaging Market Revenues & Volume, By Psychiatric Disorders, 2021- 2031F |
6.2.4 Singapore Neuroimaging Market Revenues & Volume, By Traumatic Brain Injury (TBI), 2021- 2031F |
6.3 Singapore Neuroimaging Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Singapore Neuroimaging Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.3 Singapore Neuroimaging Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.3.4 Singapore Neuroimaging Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.5 Singapore Neuroimaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.6 Singapore Neuroimaging Market Revenues & Volume, By Others, 2021- 2031F |
7 Singapore Neuroimaging Market Import-Export Trade Statistics |
7.1 Singapore Neuroimaging Market Export to Major Countries |
7.2 Singapore Neuroimaging Market Imports from Major Countries |
8 Singapore Neuroimaging Market Key Performance Indicators |
8.1 Average waiting time for neuroimaging procedures |
8.2 Number of research collaborations in neuroimaging |
8.3 Adoption rate of new neuroimaging technologies |
8.4 Patient satisfaction scores for neuroimaging services |
8.5 Rate of utilization of neuroimaging services in Singapore |
9 Singapore Neuroimaging Market - Opportunity Assessment |
9.1 Singapore Neuroimaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Singapore Neuroimaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Singapore Neuroimaging Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Singapore Neuroimaging Market - Competitive Landscape |
10.1 Singapore Neuroimaging Market Revenue Share, By Companies, 2024 |
10.2 Singapore Neuroimaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here